Home » Topics » BioWorld Science

BioWorld Science
RSS

Chinook Therapeutics identifies LDHA inhibitors

Dec. 15, 2021

Concert Pharmaceuticals presents new JAK inhibitors

Dec. 15, 2021

New pancreatic cancer immune therapy target identified

Dec. 15, 2021

Guangzhou Fermion Technology patents SST4 receptor agonists

Dec. 15, 2021

Oncolys BioPharma discloses new compounds against SARS-CoV-2 infection

Dec. 15, 2021

Siglec-15 expression is increased in leukemia and its targeting may be promising for therapy

Dec. 15, 2021

TYME-19 demonstrates antiviral effect against SARS-CoV-2 in human lung epithelial cells

Dec. 14, 2021

Ichnos grants Almirall global rights to develop and commercialize ISB-880 for autoimmune diseases

Dec. 14, 2021

CVL-218 shows promising potency and safety in preclinical models

Dec. 14, 2021

3SBio's Sunshine Guojian subsidiary to develop Numab's NM-28 in Greater China area

Dec. 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...